Search Count: 7
 |
Crystal Structure Of Mutant Cmet D1228N Kinase Domain In Complex With Inhibitor Compound 13
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.59 Å Release Date: 2024-08-21 Classification: SIGNALING PROTEIN Ligands: GOL, A1ATS |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.92 Å Release Date: 2024-08-14 Classification: SIGNALING PROTEIN Ligands: PEG, GOL, A1AN9 |
 |
Crystal Structure Of The Receptor Tyrosine Kinase Human Her2 (Erbb2) Yvma Mutant Kinase Domain In Complex With Inhibitor Compound 27
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2024-06-12 Classification: SIGNALING PROTEIN,TRANSFERASE/INHIBITOR Ligands: W9N, PEG, CL |
 |
Crystal Structure Of Non-Receptor Protein Tyrosine Phosphatase Shp2 In Complex With Pf-07284892
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.06 Å Release Date: 2024-05-29 Classification: HYDROLASE/INHIBITOR Ligands: A1AQ1 |
 |
Identification Of The Clinical Development Candidate Mrtx849, A Covalent Krasg12C Inhibitor For The Treatment Of Cancer
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.27 Å Release Date: 2020-04-22 Classification: HYDROLASE/INHIBITOR Ligands: GDP, MG, M1R |
 |
Identification Of The Clinical Development Candidate Mrtx849, A Covalent Krasg12C Inhibitor For The Treatment Of Cancer
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.03 Å Release Date: 2020-04-22 Classification: HYDROLASE/INHIBITOR Ligands: GDP, MG, QH4 |
 |
Identification Of The Clinical Development Candidate Mrtx849, A Covalent Krasg12C Inhibitor For The Treatment Of Cancer
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2020-04-22 Classification: HYDROLASE/INHIBITOR Ligands: GDP, MG, M1X |